MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11239-021-02487-3

Медицинская библиотека · Journal of thrombosis and thrombolysis · 2021

Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).

Kiris Tuncay, Avci Eyüp, Ekin Tuba, Akgün Didar Elif, Tiryaki Mücahit, Yidirim Arafat, Hazir Kutluhan, Murat Bektaş, Yeni Mehtap, Altindag Rojhad, Gül Sefa, Arik Baran, Güzel Tuncay, Murat Selda, Oz Ahmet, Karabacak Mustafa, Aktas Zihni, Yildirim Tarik, Kilicaslan Baris, Ergene Asim Oktay

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey.

METHODS

This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st-May 15st, 2020; n = 733) or pre- COVID-19 era group (March 11st-May 15st, 2019; n = 1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n = 65) or negative (n = 668).

RESULTS

There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-first medical contact time [120 (75-240) vs. 100 (60-180) minutes, p < 0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p < 0.001) and cardiogenic shock (20% vs. 7%, p < 0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p < 0.05).

CONCLUSIONS

We detected significantly lower STEMI hospitalization rates and significant delay in duration of symptom onset to first medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients.

Для цитирования: Kiris Tuncay, Avci Eyüp, Ekin Tuba, Akgün Didar Elif, Tiryaki Mücahit, Yidirim Arafat, Hazir Kutluhan, Murat Bektaş, Yeni Mehtap, Altindag Rojhad, Gül Sefa, Arik Baran, Güzel Tuncay, Murat Selda, Oz Ahmet, Karabacak Mustafa, Aktas Zihni, Yildirim Tarik, Kilicaslan Baris, Ergene Asim Oktay. Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).. Journal of thrombosis and thrombolysis. 2021. DOI: 10.1007/s11239-021-02487-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.